ASP Isotopes (NASDAQ:ASPI) Stock: Insider Robert Ainscow Sells 22,500 Shares

ASP Isotopes Inc. (NASDAQ:ASPI) COO Robert Ainscow sold 22,500 shares of ASP Isotopes stock in a transaction on Wednesday, October 14th. The stock was sold at an average price of $2.11, for a total transaction of $47,475.00. Following the completion of the sale, the chief operating officer owned 2,225,941 shares of the company’s stock, valued at approximately $4,696,735.51. This trade represents a 1.00% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Robert Ainscow also recently made the following trade(s):

• On Tuesday, September 8th, Robert Ainscow sold 8,438 shares of ASP Isotopes stock. The stock was sold at an average price of $4.29, for a total value of $36,199.02.
• On Wednesday, September 2nd, Robert Ainscow sold 25,000 shares of ASP Isotopes stock. The shares were sold at an average price of $3.90, for a total value of $97,500.00.

ASP Isotopes Stock Down 1.5%

Shares of NASDAQ ASPI opened at $2.03 on Wednesday. The company has a current ratio of 3.87, a quick ratio of 3.85 and a debt-to-equity ratio of 0.76. ASP Isotopes Inc. has a twelve month low of $1.89 and a twelve month high of $11.22. The business has a 50 day simple moving average of $3.31 and a 200-day simple moving average of $4.70.

ASP Isotopes (NASDAQ:ASPI) last released its quarterly earnings data on Friday, August 14th. The company reported ($0.28) EPS for the quarter, missing analysts’ consensus estimates of ($0.17) by ($0.11). ASP Isotopes had a negative return on equity of 64.99% and a negative net margin of 427.98%. The business had revenue of $5.12 million during the quarter, compared to analyst estimates of $4.47 million.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on the stock. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of ASP Isotopes in a report on Monday, September 21st. Wall Street Zen upgraded shares of ASP Isotopes from a “strong sell” rating to a “sell” rating in a research note on Saturday, August 22nd. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company has an average rating of “Hold” and an average target price of $13.00.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. The Manufacturers Life Insurance Company boosted its holdings in shares of ASP Isotopes by 8.8% during the first quarter. The Manufacturers Life Insurance Company now owns 30,503 shares of the company’s stock valued at $135,000 after acquiring an additional 2,470 shares during the period. Sanctuary Advisors LLC grew its position in shares of ASP Isotopes by 22.2% during the first quarter. Sanctuary Advisors LLC now owns 24,615 shares of the company’s stock worth $109,000 after acquiring an additional 4,465 shares during the last quarter. Royal Bank of Canada increased its holdings in shares of ASP Isotopes by 18.4% in the 1st quarter. Royal Bank of Canada now owns 37,954 shares of the company’s stock worth $167,000 after acquiring an additional 5,906 shares during the period. Allegheny Financial Group increased its holdings in shares of ASP Isotopes by 17.9% in the 1st quarter. Allegheny Financial Group now owns 40,649 shares of the company’s stock worth $180,000 after acquiring an additional 6,176 shares during the period. Finally, State of Wyoming acquired a new stake in shares of ASP Isotopes in the 1st quarter worth about $29,000. Institutional investors and hedge funds own 16.80% of the company’s stock.

ASP Isotopes Company Profile

ASP Isotopes Inc (NASDAQ: ASPI) is a development-stage advanced materials company focused on isotope enrichment. The company is developing proprietary technology intended to separate and enrich isotopes for use in several high-value markets, including nuclear energy, medicine, semiconductors, quantum computing and other industrial applications.

ASP Isotopes has described its platform as being designed to provide more efficient and scalable isotope production than certain conventional enrichment methods.